rs7133258
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000556029.6(TMPO):āc.859G>Cā(p.Ala287Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,612,944 control chromosomes in the GnomAD database, including 141 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000556029.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMPO | NM_001032283.3 | c.859G>C | p.Ala287Pro | missense_variant | 6/9 | ENST00000556029.6 | NP_001027454.1 | |
TMPO | NM_001307975.2 | c.739G>C | p.Ala247Pro | missense_variant | 5/8 | NP_001294904.1 | ||
TMPO | NM_001032284.3 | c.664-1842G>C | intron_variant | NP_001027455.1 | ||||
TMPO | XM_005269132.5 | c.664-434G>C | intron_variant | XP_005269189.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMPO | ENST00000556029.6 | c.859G>C | p.Ala287Pro | missense_variant | 6/9 | 1 | NM_001032283.3 | ENSP00000450627 |
Frequencies
GnomAD3 genomes AF: 0.00919 AC: 1397AN: 152078Hom.: 17 Cov.: 33
GnomAD3 exomes AF: 0.0104 AC: 2607AN: 251018Hom.: 31 AF XY: 0.0102 AC XY: 1386AN XY: 135760
GnomAD4 exome AF: 0.0102 AC: 14901AN: 1460750Hom.: 124 Cov.: 31 AF XY: 0.00991 AC XY: 7199AN XY: 726716
GnomAD4 genome AF: 0.00918 AC: 1397AN: 152194Hom.: 17 Cov.: 33 AF XY: 0.0107 AC XY: 797AN XY: 74398
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 06, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | TMPO: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 21, 2012 | Ala287Pro in exon 6 of TMPO: This variant is not expected to have clinical signi ficance because it has been identified in 1.0% (85/8600) of European American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs7133258). Ala287Pro in exon 6 of TMPO (rs713 3258; allele frequency= 1.0%, 85/8600) ** - |
TMPO-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at